Articles Tagged With:
-
OCR’s Update on Online Tracking Guidance Still Tricky
The Office for Civil Rights (OCR) recently updated its December 2022 bulletin regarding the use of third-party tracking technologies by HIPAA-regulated entities “to increase clarity for regulated entities and the public.” However, the clarity is questionable.
-
Review Cyber Risk Insurance, Brace for Transparency Issues
Pay attention to your policies for cyber insurance or data liability when they come up for renewal or if you are in the process of obtaining them,
-
State Laws Affect Privacy Compliance; Data Tracking Also a Concern
New state privacy laws can affect hospital operations but might be overlooked when the focus is on HIPAA compliance.
-
Falls Remain a Leading Safety Problem, Still Need Attention
Risk managers must not let their guard down on the perennial patient safety concern of falls, looking to the proven methods of prevention and the sometimes simple steps that can have significant effect.
-
Stigmatizing Language Can Lead to Diagnostic Errors, Patient Harm
Stigmatizing language is inappropriate in healthcare and can easily seep into documentation and verbal communication. One of the worst effects of such comments is that it can lead to diagnostic errors and other threats to patient safety, according to recent research.
-
Safety II Framework Aims to Improve Safety, Eliminate Useless Tasks
A better approach to patient safety can eliminate much of the useless and redundant tasks that burden clinicians and do little to avoid harm, says a researcher who encourages risk managers to consider the natural tendencies of people in the workplace.
-
CMS Moving to Address Patient Harm with Additional Measures
Centers for Medicare & Medicaid Services is planning to introduce additional requirements to improve patient safety, and risk managers would be wise to anticipate how those new measures might affect their operations.
-
New Noncompete Rule Requires Reevaluation of Healthcare Agreements
A recent decision by the Federal Trade Commission changes how healthcare organizations can limit the activities of employees after they resign or are terminated, requiring a review of any noncompete agreements currently in place and policies that require them..
-
Results from GLP-1 Receptor Agonists in Early Parkinson’s Disease
This paper demonstrated that after one year of treatment, lixisenatide resulted in less progression of motor disability. Longer studies are needed to determine if this represents true disease modification.
-
Brentuximab Neuropathy
Brentuximab, an antibody-drug conjugate for the treatment of lymphomas, carries a high risk of inflammatory sensory and motor neuropathies.